Early clinical trials are showing that the H1F1 flu vaccine is working with just one shot or dose, instead of two, The New York Times reported -- and that means vaccine supplies will go twice as far as predicted. The significance? If the one-shot treatment holds, that means it should be possible to vaccinate all 159 million people in the Centers for Disease Control and Prevention's high risk groups: pregnant women, people under age 24 or caring for infants, people with high-risk medical conditions, and health care workers.
First dose batches coming in early October
In a related development U.S. Health Secretary Kathleen Sebelius said the United States now expects to receive the first batch of flu vaccine in early October, a few weeks earlier than expected, the Agence France-Presse reported Sunday.
The accelerated delivery will likely gladden the hearts of health administrators, educators, and parents alike, who were concerned about a rise in flu cases and/or the late arrival of vaccines to deal with the viral threat.
The H1N1 flu did not fade as seasonal flu does in the late spring and summer, but persisted, especially in summer camps, The Times reported. The initial trials of the vaccine show that adults who got only a single dose were protected within eight to ten days.
Comment: Here's hoping the initial trials of 1-dose protection hold. Having taught at the college level for several years, I can attest that an early start to the virus/flu season has occurred, at least in the New York metropolitan area: I can't recall a year in which there were so many students coughing, sneezing, and wheezing at the start of fall classes in September.
Impact on Investors: If the H1N1 vaccine substantially decreases the incidence of the flu in 2010, that could further support U.S. GDP growth and the recovery. The reason? Less lost productivity from employees who miss work, due to the illness. All other factors being equal, the healthier the workforce is (including the absence of the flu), the more productive it is.
Entrepreneur's Journal: Want to get a piece of the Buffett/Goldman honeypot?
The week in preview: No turkey earnings from Tyson, Hormel, Cracker Barrel ...
Comfort Zone Investing: Intel is saying something ... can you hear it?
Reader Comments (Page 1 of 1)
9-15-2009 @ 2:03PM
Roger Pelizzari said...
People are refusing to believe the government propaganda. Polls show that the majority of people in the US now believe the swine flu vaccine may be deadlier than the actual virus.
Additionally, research published in the August 25 issue of the British Medical Journal reveals that more than half of doctors and nurses in public hospitals would also refuse the H1N1 vaccine, due to concerns about side effects and doubts about its efficacy.
New Potential Health Risks of the Swine Flu Vaccine Emerge
Just last week a confidential letter between the British Health Protection Agency and 600 neurologists leaked to the press. It warned them of possible cases of Guillain- Barré Syndrome once the swine flu vaccine campaign begins.
Vaccine ingredients such as mercury, and squalene, have been linked to the development of autoimmune diseases like rheumatoid arthritis and lupus. There is no way to shut off the immune system activation once the squalene has been injected, which is why it is so dangerous. There is a MILLION times more squalene in this vaccine than in the Vaccine A which caused the Gulf War Syndrome.
Now, German lung specialist Wolfgang Wodarg, chairman of the health committee in the German parliament and European Council, warns of an even worse health risk of the vaccine. The swine flu vaccine contains animal cancer cells, and there’s no data indicating whether or not this may cause an allergic reaction when injected. This also raises questions about the risk of contracting cancer.
Dr. Wodarg also told the German press that the widespread fear of the pandemic was an “orchestration,” stating,
“It is great business for the pharmaceutical industry. Swine flu is not very different from normal flu. On the contrary, if you look at the number of cases it is nothing compared to a normal flu outbreak.”
More Documentation about Swine Flu Vaccine Safety
A recent article by Dr. Blaylock also highlights the many reasons why the vaccine may be far more dangerous than the virus. He states that the Baxter swine flu vaccine, called Celvapan, uses cultured cells from the African green monkey, which has previously been implicated as having transmitted a number of vaccine-contaminating viruses, including the HIV virus.
Likewise, Johannes Löwer, president of the Paul Ehrlich Institute, believes the side effects of the vaccine can be far worse than the actual swine flu virus, which typically causes only mild symptoms, requiring just a few days in bed.
Based on a rational view of the numbers involved, the widespread fear over the swine flu is completely unwarranted. It has claimed far fewer lives than the regular seasonal flu and even that flu's yearly toll has been grossly exaggerated by the CDC due to flawed data compilation.
Even the WHO's estimates of swine flu deaths are totally wrong because many countries are mixing in normal flu figures with those of the swine flu.
Industry Versus Independent Research Findings -- Who are You Going to Believe?
Dr. Blaylock reports that the human test studies that claimed the vaccine safe were all done by the pharmaceutical companies.
However, a great number of the studies done by independent research facilities all found a strong link between squalene or MF-59 (which contains squalene) and autoimmune diseases.
Dr. Blaylock warns,
“Studies of other immune adjuvants using careful tracer techniques have shown that they routinely enter your brain following vaccination.
What most people do not know, even the doctors who recommend the vaccines, is that most such studies by pharmaceutical companies observe the patients for only one to two weeks following vaccination—these types of reactions may take months or even years to manifest.”
This is a major point.
If you were to develop an autoimmune disease years down the line, how would you ever be able to prove that your disease originated in a needle?
And worse, even if you could prove it, it wouldn’t do you any good, because vaccine manufacturers have cleverly manipulated government into granting them immunity against lawsuits, should any harm be caused by this experimental vaccine.
Why You Should Avoid Other Anti-Virals as Well
British researchers recently warned that the antiviral medication Tamiflu is “inappropriate for healthy adults.”
"Recommending the use of antiviral drugs for the treatment of people presenting with [flu] symptoms is unlikely to be the most appropriate course of action," they concluded.
The study, published in the Lancet Infectious Diseases, recommends that healthy people who get the swine flu should NOT be treated with antivirals like Tamiflu or Relenza, unless they suffer complications from the flu.
Based on their findings, either drug will reduce your illness by about HALF A DAY.
For people with health conditions like diabetes or asthma, Relenza was able to cut sickness by just under one full day, and Tamiflu by three-quarters of a day, on average.